BioNTech Signs Rare Disease Co-Development Deal With Genevant & Licenses LNP Platform
2018
report
Zugriff:
Titel: |
BioNTech Signs Rare Disease Co-Development Deal With Genevant & Licenses LNP Platform
|
---|---|
Autor/in / Beteiligte Person: | Ward, Mike |
Link: | |
Veröffentlichung: | 2018 |
Medientyp: | report |
Sonstiges: |
|